Obesity

President of the Obesity Medicine Association discusses how clinician perspectives on obesity and obesity treatment are changing for the better.

In an open letter to the public, Lilly decries use of tirzepatide products Mounjaro and Zepbound for nonmedical purposes and warns of counterfeit formulations.

Findings underscore the importance of preventive measures and management of risk factors associated with CKD in adolescents with elevated BMI, report researchers.

Angela Fitch, MD, discusses the importance of clinician education in addressing obesity with patients.

President of the Obesity Medicine Association discusses a recent joint statement from the OMA and 4 other organizations calling for inclusion of patients with obesity in drug research.

Your daily dose of the clinical news you may have missed.

Angela Fitch, MD, president of the Obesity Medicine Association discusses key pharmaceutical and research developments in obesity medicine in 2023.

Your daily dose of the clinical news you may have missed.

The American Board of Obesity Medicine says annual first-time certificates now exceed those for cardiology, pulmonology, and medical oncology.

The task force recommends clinicians provide or refer children and adolescents with a high BMI to intensive, comprehensive behavioral interventions.